IDXG

Interpace Biosciences, Inc. Common Stock

IDXG

Delisted

IDXG was delisted on the 24th of February, 2021.

29 hedge funds and large institutions have $37.1M invested in Interpace Biosciences, Inc. Common Stock in 2013 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 15 closing their positions.

New

Increased

Maintained

Reduced

Closed

less capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders

Holders Change

Holders Change %

% of All Funds

Holding in Top 10

–

Holding in Top 10 Change

Holding in Top 10 Change %

% of All Funds

New

Increased

Reduced

Closed

Calls

–

Puts

–

Net Calls

Net Calls Change

Top Buyers

1		+$1.09M
2		+$530K
3		+$33.7K
4	Jacobs Levy Equity Management Florham Park, New Jersey	+$22.2K
5	BFA BlackRock Fund Advisors San Francisco, California	+$10.6K

Top Sellers

1		-$1.09M
2		-$673K
3		-$355K
4	PP Paloma Partners Greenwich, Connecticut	-$205K
5	CI Cowen Inc New York	-$163K

#	Name	Holding
26	26	$9K
27	27	$8K
28	28	$6K
29	29	$5
30	30	–
31	31	–
32	32	–
33	33	–
34	34	–
35	35	–
36	36	–
37	37	–
38	38	–
39	39	–
40	40	–
41	41	–
42	42	–
43	43	–

#	Name	Holding
26	26	$9K
27	27	$8K
28	28	$6K
29	29	$5
30	30	–
31	31	–
32	32	–
33	33	–
34	34	–
35	35	–
36	36	–
37	37	–
38	38	–
39	39	–
40	40	–
41	41	–
42	42	–
43	43	–

#	Name	Holding
26	26	$9K
27	27	$8K
28	28	$6K
29	29	$5
30	30	–
31	31	–
32	32	–
33	33	–
34	34	–
35	35	–
36	36	–
37	37	–
38	38	–
39	39	–
40	40	–
41	41	–
42	42	–
43	43	–

Interpace Biosciences, Inc. Common Stock IDXG